Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs
Summary Google DeepMind’s spinoff, Isomorphic Labs, is gearing up to begin human trials of its AI-designed drugs. With the chief business officer, Colin Murdoch, claiming they’re getting “very close” to…
